Nicholas Larsen

Nicholas Larsen

Company: H3 Biomedicine

Job title: Director of Lead Discovery


Spliceosome Modulation – Harnessing the Spliceosome to Target pre-mRNA Splice Factors 9:30 am

• Outlining spliceosome mutations in cancer • Rethinking effects of indirect targeting of RNA via spliceosome for delivery of a potential therapeutic target • Assessing the methodologies and technologies to effectively drug the spliceosome • Future applications and perspectives of targeting the spliceosomeRead more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.